Asthma Research

Innovative clinical studies focusing on severe asthma management and new therapeutic approaches. Research includes evaluation of novel treatments like lunsekimig and tezepelumab for patients with difficult-to-control asthma symptoms.

  • High-risk asthma treatment evaluation
  • Oral corticosteroid reduction strategies
  • Novel therapeutic assessments

These trials aim to improve treatment options for patients dependent on oral corticosteroids and those with severe asthma manifestations.

Rare Disease Studies

Groundbreaking research investigating treatments for Hypereosinophilic Syndrome (HES), with particular focus on benralizumab’s potential therapeutic benefits in managing this rare condition.

  • HES flare prevention
  • Disease progression monitoring
  • Novel treatment approaches

The research aims to establish effective interventions for this challenging hematologic disorder.

COPD Research

Comprehensive studies examining chronic obstructive pulmonary disease treatments, including evaluation of triple therapy combinations and new delivery systems for established medications.

  • Cardiopulmonary outcomes assessment
  • Inhaler technology advancement
  • Exacerbation reduction strategies

These trials focus on improving lung function and reducing exacerbation frequency in moderate to severe COPD patients.